Discover a study where results suggest that while MASLD is common in patients with T2DM in primary care, advanced liver ...

The Global Liver Institute urges worldwide integration of liver health into diabetes and obesity care as steatotic liver ...

Six out of 10 people with type 2 diabetes had fatty liver in a new study from Linköping University. Of these, only a small ...

"The POSITANO study shows that CAM2029 significantly reduces liver and liver cyst volume compared to placebo while showing improvements in symptoms as assessed by relevant patient ...

Follow-up reached a median 5.5 years overall. Adverse liver outcomes in question counted cirrhosis, decompensation, ...

A shocking new study shows a significant connection between type 2 diabetes and liver diseases, highlighting the increased ...

Of 4,056,287 hospitalizations of patients with chronic liver disease (mean age, 58.3 years; 55.4% men), 44.9% had Medicare and 26% had Medicaid.

Primary sclerosing cholangitis, PSC in short, is a rare liver disease that destroys the bile ducts. It is a severe condition ...

Dapagliflozin, a SGLT2 inhibitor used for type 2 diabetes, alleviates steatohepatitis and fibrosis in patients with ...

Six out of ten people with type 2 diabetes had fatty liver in a new study from Linköping University in Sweden. Of these, only ...

Nonalcoholic fatty liver disease (NAFLD) was linked to elevated liver enzymes in type 2 diabetes mellitus (T2DM) in a recent ...

Background Metabolic dysfunction-associated steatotic liver disease (MASLD) affects over 30% of the general population and is ...